JG
ELV icon

Jefferies Group’s Elevance Health ELV Stock Holding History

Jefferies Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,600
Closed -$1.34M – 1728
2021
Q3 		$1.34M Buy
+3,600
New +$1.37M 0.01% 889
2021
Q1 		– Sell
-6,500
Closed -$2.09M – 1725
2020
Q4 		$2.09M Buy
+6,500
New +$1.99M 0.02% 697
2020
Q2 		– Sell
-15,700
Closed -$3.62M – 1515
2020
Q1 		$3.62M Sell
15,700
-5,500
-26% -$1.5M 0.04% 431
2019
Q4 		$6.4M Buy
21,200
+4,700
+28% +$1.29M 0.05% 408
2019
Q3 		$3.96M Sell
16,500
-75,300
-82% -$20.6M 0.03% 654
2019
Q2 		$25.9M Buy
91,800
+61,300
+201% +$16.7M 0.19% 73
2019
Q1 		$8.75M Buy
30,500
+25,100
+465% +$7.26M 0.07% 244
2018
Q4 		$1.42M Sell
5,400
-4,800
-47% -$1.32M 0.01% 988
2018
Q3 		$2.79M Buy
10,200
+2,500
+32% +$649K 0.02% 820
2018
Q2 		$1.83M Buy
7,700
+4,100
+114% +$949K 0.01% 941
2018
Q1 		$791K Buy
3,600
+2,000
+125% +$470K ﹤0.01% 1295
2017
Q4 		$360K Buy
1,600
+200
+14% +$42.6K ﹤0.01% 1920
2017
Q3 		$266K Sell
1,400
-22,800
-94% -$4.34M ﹤0.01% 1937
2017
Q2 		$4.55M Sell
24,200
-2,000
-8% -$359K 0.03% 576
2017
Q1 		$4.33M Buy
26,200
+17,600
+205% +$2.8M 0.03% 554
2016
Q4 		$1.24M Buy
8,600
+3,800
+79% +$509K 0.01% 1155
2016
Q3 		$601K Sell
4,800
-18,300
-79% -$2.36M ﹤0.01% 1539
2016
Q2 		$3.03M Sell
23,100
-30,600
-57% -$4.19M 0.01% 700
2016
Q1 		$7.46M Buy
53,700
+10,500
+24% +$1.4M 0.04% 336
2015
Q4 		$6.02M Buy
+43,200
New +$5.95M 0.03% 390
2015
Q1 		– Sell
-40,800
Closed -$5.13M – 2171
2014
Q4 		$5.13M Buy
+40,800
New +$5.04M 0.03% 415

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Jefferies Group's ELV Position: Q2 2022 in Review

Jefferies Group sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 1,000 shares — an estimated $491K sold.

Jefferies Group first reported a position in ELV in Q2 2013 and held it in 35 quarters. The position peaked at $20.6M in Q3 2021. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • Jefferies Group reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
  • Jefferies Group sold 1,000 Elevance Health shares in Q2 2022, an estimated $491K.
  • Jefferies Group first reported a position in Elevance Health in Q2 2013 and held it in 35 quarters.
  • Jefferies Group's Elevance Health position peaked at $20.6M in Q3 2021.
  • 1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.